Regeneron Pharmaceuticals
Regeneron is a leading biotechnology company that invents, develops, and commercializes life-transforming medicines for people with serious diseases. Learn more
Launch date
Employees
Market cap
$128.4b
Enterprise valuation
$121.3b (Public information from Sep 2024)
Share price
$1138.81006 REGN
Town of Greenburgh New York (HQ)
Corporate Venture Fund: Regeneron Ventures
Authorizing premium user...